11 min listen
Elisabeth Schorb on the MARTA phase 2 trial
Elisabeth Schorb on the MARTA phase 2 trial
ratings:
Length:
9 minutes
Released:
Feb 29, 2024
Format:
Podcast episode
Description
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Feb 29, 2024
Format:
Podcast episode
Titles in the series (43)
The Lancet Haematology: December 1, 2014 by The Lancet Haematology in conversation with